17-alpha-hydroxyprogesterone has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drafta, D; Neacşu, E; Proca, E; Schindler, AE; Stroe, E; Zamfir, V | 1 |
| Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Adenoma, Prostatic
| Article | Year |
|---|---|
Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Topics: 17-alpha-Hydroxyprogesterone; Age Factors; Aged; Dihydrotestosterone; Estradiol; Estrone; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Middle Aged; Progesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Reference Values; Testosterone | 1982 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |